查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1508636

脑功能成像系统市场:全球产业分析，规模，占有率，成长，趋势，预测，2024年～2033年

Functional Brain Imaging Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 310 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于功能性脑影像系统全球市场的综合报告。该报告全面评估了主要市场动态，包括市场驱动因素、趋势、机会和课题，并提供了有关市场结构的详细见解。

关键见解

  • 功能性脑部影像系统市场规模（2024 年）：50.75 亿美元
  • 预测市场规模（2033 年）：90.21 亿美元
  • 全球市场成长率（2024-2033 年复合年增长率）：6.6%

脑功能影像系统市场 - 研究范围：

功能性脑部影像系统在阿兹海默症、癫痫、精神分裂症、脑肿瘤等多种神经和精神疾病的诊断和治疗中发挥重要作用。这些系统利用 fMRI、PET、SPECT 和 MEG 等先进影像技术来绘製大脑活动图，为大脑功能提供有价值的见解，并帮助开发针对性治疗。功能性脑部影像系统市场面向医院、研究机构、诊断中心和学术机构，提供多种影像模式以满足不同的临床和研究需求。

市场驱动因素：

全球功能性脑部影像系统市场由几个关键因素推动，包括神经系统疾病盛行率的增加、影像技术的进步以及对非侵入性诊断方法的需求不断增加。人们对早期诊断和个人化治疗计划的好处的认识不断提高将进一步支持市场扩张。高解析度成像系统和便携式成像设备的市场开发等技术创新提高了诊断准确性和患者舒适度，推动了市场成长。此外，功能性脑部造影在认知神经科学研究和製药行业中的日益增长的应用为市场参与者提供了利用先进成像解决方案的新机会。

市场限制因素：

儘管成长前景广阔，但功能性脑部造影系统市场面临设备成本高、报销范围有限和严格的监管要求等课题。特别是在医疗保健预算有限的新兴国家，功能性脑影像系统的高价格和相关的营运成本是其引入的障碍。此外，成像程序的报销限制和管理医疗成像设备的复杂监管环境进一步影响市场成长。应对这些经济和监管课题需要利益相关者共同努力，推广具有成本效益的解决方案并简化监管途径。

市场机会：

由于技术进步、研究应用的扩大和医疗保健投资的增加，功能性脑部造影系统市场提供了巨大的成长机会。将人工智慧和机器学习整合到诊断成像系统中可以增强影像分析和解释，从而提高诊断准确性和效率。此外，人们对大脑健康的兴趣日益浓厚，神经退化性疾病的盛行率不断上升，刺激了对先进影像技术的需求。策略联盟、研发投资以及推出用户友好且具有成本效益的成像解决方案对于利用新的商机并保持在动态功能性脑成像市场的领先地位至关重要。

本报告涵盖的主要问题

  • 推动功能性脑部造影系统市场全球成长的关键因素是什么？
  • 哪些影像模式和应用正在推动各种医疗机构的采用？
  • 技术进步如何改变功能性脑部影像系统市场的竞争格局？
  • 谁是功能性脑部影像系统市场的主要参与者？
  • 全球功能性脑部影像系统市场的新趋势和未来前景是什么？

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围/分类
  • 市场定义/范围/限制
  • 涵括和排除

第3章 主要市场趋势

  • 影响市场的主要趋势
  • 产品革新/开发趋势

第4章 重要成功要素

  • 产品采用分析
  • 主要的法规
  • 偿付情势
  • 价值链分析
  • PESTEL分析
  • 波特分析
  • 由于主要业者的主要的推销策略

第5章 市场背景

  • 宏观经济要素
  • 预测要素- 相关性及影响
  • 市场动态

第6章 COVID-19危机分析

  • COVID-19及影响分析
    • 各产品
    • 各种模式
    • 各终端用户
    • 各国
  • 2024年的市场情势

第7章 全球脑功能成像系统市场需求(数量(单位)分析)

  • 过去的市场数量(单位)分析，2019年～2023年
  • 现在及未来市场规模(单位)预测，2024年～2033年
    • 前一年同期比较成长趋势分析

第8章 全球脑功能成像系统市场- 价格分析

  • 各产品的各地区价格分析
  • 价格的明细
    • 厂商层级的价格设定
    • 分销商层级的价格设定
  • 世界平均价格分析基准
  • 价格设定的前提

第9章 全球脑功能成像系统市场需求(价值或规模，10亿美元)分析

  • 市场金额(10亿美元)的过去分析，2019年～2023年
  • 现在及未来市场金额(10亿美元)预测，2024年～2033年
    • 前一年同期比较成长趋势分析
    • 绝对的美元机会分析

第10章 全球脑功能成像系统市场分析:各产品

  • 简介/主要调查结果
  • 各产品的市场规模(10亿美元)和数量(单位)的过去分析，2019年～2023年
  • 各产品的现在及未来市场规模(10亿美元)和数量(单位)的分析与预测，2024年～2033年
    • 功能的 MR影像(fMRI)系统
    • 功能的近红外线光谱法(fNIRS)系统
    • 磁脑波检验(MEG)系统
    • 正子放出断层摄影(PET)系统
    • 脑波检验(EEG)系统
  • 各产品市场魅力分析

第11章 全球脑功能成像系统市场分析:各种模式

  • 简介/主要调查结果
  • 各种模式的市场规模(10亿美元)的过去分析，2019年～2023年
  • 各种模式的现在及未来市场规模(10亿美元)分析与预测，2024年～2033年
    • 独立的设备
    • 行动装置
  • 各种模式市场魅力分析

第12章 全球脑功能成像系统市场分析:各终端用户

  • 简介/主要调查结果
  • 各终端用户的市场规模(10亿美元)的过去分析，2019年～2023年
  • 各终端用户的现在及未来市场规模(10亿美元)分析与预测，2024年～2033年
    • 医院
    • 办公室为基础的诊所
    • 门诊病人手术中心
    • 影像诊断中心
  • 各终端用户市场魅力分析

第13章 全球脑功能成像系统市场分析:各地区

  • 简介
  • 各地区的市场规模(10亿美元)数量(单位)的过去分析
  • 各地区的现在及未来市场金额(10亿美元)和数量(单位)分析与预测，2024年～2033年
    • 北美
    • 南美
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东及非洲
  • 各地区市场的魅力分析

第14章 北美的脑功能成像系统市场分析

第15章 南美的脑功能成像系统市场分析

第16章 欧洲的脑功能成像系统市场分析

第17章 东亚的脑功能成像系统市场分析

第18章 南亚的脑功能成像系统市场分析

第19章 大洋洲的脑功能成像系统市场

第20章 中东及非洲脑功能成像系统市场分析

第21章 市场结构分析

  • 各级企业市场分析
  • 主要企业的市场占有率分析
  • 市场影响分析

第22章 竞争分析

  • 竞争仪表板
  • 竞争详细内容
    • Koninklijke Philips NV
    • General Electric Company
    • Canon Medical Systems Corporation
    • EB Neuro SpA
    • MinFound Medical Systems Co., Ltd
    • Neurosoft
    • Medtronic Plc
    • Nihon Kohden Corporation
    • Hitachi Medical Systems
    • Elekta
    • Siemens AG

第23章 所使用的假设和缩写

第24章 调查手法

简介目录
Product Code: PMRREP23050

Persistence Market Research has recently released a comprehensive report on the worldwide market for functional brain imaging systems. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Functional Brain Imaging Systems Market Size (2024E): USD 5.075 Billion
  • Projected Market Value (2033F): USD 9.021 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 6.6%

Functional Brain Imaging Systems Market - Report Scope:

Functional brain imaging systems play a crucial role in the diagnosis and treatment of various neurological and psychiatric conditions, including Alzheimer's disease, epilepsy, schizophrenia, and brain tumors. These systems utilize advanced imaging techniques such as fMRI, PET, SPECT, and MEG to map brain activity, providing valuable insights into brain function and aiding in the development of targeted therapies. The market for functional brain imaging systems caters to hospitals, research institutions, diagnostic centers, and academic institutions, offering a range of imaging modalities to suit diverse clinical and research needs.

Market Growth Drivers:

The global functional brain imaging systems market is propelled by several key factors, including increasing prevalence of neurological disorders, advancements in imaging technology, and growing demand for non-invasive diagnostic methods. Rising awareness about the benefits of early diagnosis and personalized treatment plans further drive market expansion. Technological innovations, such as the development of high-resolution imaging systems and portable imaging devices, enhance diagnostic accuracy and patient comfort, fostering market growth. Moreover, the expanding application of functional brain imaging in cognitive neuroscience research and the pharmaceutical industry creates new opportunities for market players to leverage advanced imaging solutions.

Market Restraints:

Despite promising growth prospects, the functional brain imaging systems market faces challenges related to high equipment costs, limited reimbursement coverage, and stringent regulatory requirements. The high cost of functional brain imaging systems and the associated operational expenses pose barriers to adoption, particularly in emerging economies with constrained healthcare budgets. Limited reimbursement for imaging procedures and the complex regulatory landscape governing medical imaging devices further impact market growth. Addressing these economic and regulatory challenges requires concerted efforts from industry stakeholders to promote cost-effective solutions and streamline regulatory pathways.

Market Opportunities:

The functional brain imaging systems market presents significant growth opportunities driven by technological advancements, expanding research applications, and increasing healthcare investments. The integration of artificial intelligence and machine learning in imaging systems enhances image analysis and interpretation, improving diagnostic accuracy and efficiency. Furthermore, the growing focus on brain health and the rising incidence of neurodegenerative diseases stimulate demand for advanced imaging technologies. Strategic collaborations, investment in research and development, and the introduction of user-friendly, cost-effective imaging solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic functional brain imaging landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the functional brain imaging systems market globally?
  • Which imaging modalities and applications are driving adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the functional brain imaging systems market?
  • Who are the key players contributing to the functional brain imaging systems market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global functional brain imaging systems market?

Competitive Intelligence and Business Strategy:

Leading players in the global functional brain imaging systems market, including GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced imaging solutions, including high-resolution fMRI, PET-CT, and portable MEG systems, catering to diverse clinical and research needs. Collaborations with healthcare providers, research institutions, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving brain imaging landscape.

Key Companies Profiled:

  • Koninklijke Philips N.V.
  • General Electric Company
  • Canon Medical Systems Corporation
  • EB Neuro S.p.A.
  • MinFound Medical Systems Co., Ltd
  • Neurosoft
  • Medtronic Plc
  • Nihon Kohden Corporation
  • Siemens AG
  • Hitachi Medical Systems
  • Elekta

Key Segments Covered in Functional Brain Imaging Systems Industry Research

Product:

  • Functional MR Imaging (fMRI) System
  • Functional Near Infrared Spectroscopy (fNIRS) System
  • Magnetoencephalography (MEG) System
  • Positron Emission Tomography (PET) System
  • Electroencephalography (EEG) System

Modality:

  • Stand-Alone Device
  • Portable Device

End User:

  • Hospitals
  • Office Based Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Imaging Centers

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Analysis
  • 4.2. Key Regulations
  • 4.3. Reimbursement scenario
  • 4.4. Value Chain Analysis
  • 4.5. PESTEL Analysis
  • 4.6. Porter's Analysis
  • 4.7. Key Promotional Strategies, By Key Players

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Medical Imaging Equipment Market Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rising Incidents of Brain Disorders
    • 5.2.2. Introduction of Novel Products
    • 5.2.3. Rising Volumes of Surgical Procedure
    • 5.2.4. Adoption Rate of Functional Brain Imaging Systems
    • 5.2.5. Rising Geriatric Population
    • 5.2.6. Increasing Government Spending and Investments
    • 5.2.7. Technological Advancements
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Modality
    • 6.1.3. By End User
    • 6.1.4. By Country
  • 6.2. 2024 Market Scenario

7. Global Functional Brain Imaging Systems Market Demand (in Volume (Units)) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Functional Brain Imaging Systems Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Product
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Functional Brain Imaging Systems Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
    • 10.3.1. Functional MR Imaging (fMRI) System
    • 10.3.2. Functional Near Infrared Spectroscopy (fNIRS) System
    • 10.3.3. Magenetoencephalography (MEG) System
    • 10.3.4. Positron Emission Tomography (PET) System
    • 10.3.5. Electroencephalography (EEG) System
  • 10.4. Market Attractiveness Analysis By Product

11. Global Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Modality

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis By Modality, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Modality, 2024-2033
    • 11.3.1. Stand-Alone Device
    • 11.3.2. Portable Device
  • 11.4. Market Attractiveness Analysis By Modality

12. Global Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 12.3.1. Hospitals
    • 12.3.2. Office Based Clinics
    • 12.3.3. Ambulatory Surgical Centers
    • 12.3.4. Diagnostic Imaging Centers
  • 12.4. Market Attractiveness Analysis By End User

13. Global Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019-2023
  • 13.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Modality
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Modality
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Key Players - Intensity Mapping
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. U.S. Functional Brain Imaging Systems Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Modality
        • 14.8.1.2.3. By End User
    • 14.8.2. Canada Functional Brain Imaging Systems Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Modality
        • 14.8.2.2.3. By End User

15. Latin America Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Mexico
      • 15.3.1.2. Brazil
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By Modality
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Modality
    • 15.4.4. By End User
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Key Players - Intensity Mapping
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Mexico Functional Brain Imaging Systems Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Modality
        • 15.8.1.2.3. By End User
    • 15.8.2. Brazil Functional Brain Imaging Systems Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Modality
        • 15.8.2.2.3. By End User
    • 15.8.3. Argentina Functional Brain Imaging Systems Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Modality
        • 15.8.3.2.3. By End User

16. Europe Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Russia
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By Modality
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Modality
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Key Players - Intensity Mapping
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Germany Functional Brain Imaging Systems Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Modality
        • 16.8.1.2.3. By End User
    • 16.8.2. Italy Functional Brain Imaging Systems Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Modality
        • 16.8.2.2.3. By End User
    • 16.8.3. France Functional Brain Imaging Systems Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Modality
        • 16.8.3.2.3. By End User
    • 16.8.4. U.K. Functional Brain Imaging Systems Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Modality
        • 16.8.4.2.3. By End User
    • 16.8.5. Spain Functional Brain Imaging Systems Market Analysis
      • 16.8.5.1. Introduction
      • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.5.2.1. By Product
        • 16.8.5.2.2. By Modality
        • 16.8.5.2.3. By End User
    • 16.8.6. BENELUX Functional Brain Imaging Systems Market Analysis
      • 16.8.6.1. Introduction
      • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.6.2.1. By Product
        • 16.8.6.2.2. By Modality
        • 16.8.6.2.3. By End User
    • 16.8.7. Russia Functional Brain Imaging Systems Market Analysis
      • 16.8.7.1. Introduction
      • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.7.2.1. By Product
        • 16.8.7.2.2. By Modality
        • 16.8.7.2.3. By End User

17. East Asia Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Product
    • 17.3.3. By Modality
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Modality
    • 17.4.4. By End User
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Key Players - Intensity Mapping
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. China Functional Brain Imaging Systems Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Modality
        • 17.8.1.2.3. By End User
    • 17.8.2. Japan Functional Brain Imaging Systems Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Modality
        • 17.8.2.2.3. By End User
    • 17.8.3. South Korea Functional Brain Imaging Systems Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Modality
        • 17.8.3.2.3. By End User

18. South Asia Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Indonesia
      • 18.3.1.3. Malaysia
      • 18.3.1.4. Thailand
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Product
    • 18.3.3. By Modality
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Modality
    • 18.4.4. By End User
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Key Players - Intensity Mapping
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. India Functional Brain Imaging Systems Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Modality
        • 18.8.1.2.3. By End User
    • 18.8.2. Indonesia Functional Brain Imaging Systems Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Modality
        • 18.8.2.2.3. By End User
    • 18.8.3. Malaysia Functional Brain Imaging Systems Market Analysis
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By Modality
        • 18.8.3.2.3. By End User
    • 18.8.4. Thailand Functional Brain Imaging Systems Market Analysis
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.4.2.1. By Product
        • 18.8.4.2.2. By Modality
        • 18.8.4.2.3. By End User

19. Oceania Functional Brain Imaging Systems Market 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By Modality
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Modality
    • 19.4.4. By End User
  • 19.5. Market Trends
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Key Players - Intensity Mapping
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. Australia Functional Brain Imaging Systems Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Modality
        • 19.8.1.2.3. By End User
    • 19.8.2. New Zealand Functional Brain Imaging Systems Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Modality
        • 19.8.2.2.3. By End User

20. Middle East and Africa (MEA) Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkey
      • 20.3.1.3. North Africa
      • 20.3.1.4. South Africa
      • 20.3.1.5. Rest of Middle East and Africa
    • 20.3.2. By Product
    • 20.3.3. By Modality
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By Modality
    • 20.4.4. By End User
  • 20.5. Market Trends
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Key Players - Intensity Mapping
  • 20.8. Country Level Analysis & Forecast
    • 20.8.1. GCC Countries Functional Brain Imaging Systems Market Analysis
      • 20.8.1.1. Introduction
      • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.1.2.1. By Product
        • 20.8.1.2.2. By Modality
        • 20.8.1.2.3. By End User
    • 20.8.2. Turkey Functional Brain Imaging Systems Market Analysis
      • 20.8.2.1. Introduction
      • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.2.2.1. By Product
        • 20.8.2.2.2. By Modality
        • 20.8.2.2.3. By End User
    • 20.8.3. South Africa Functional Brain Imaging Systems Market Analysis
      • 20.8.3.1. Introduction
      • 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.3.2.1. By Product
        • 20.8.3.2.2. By Modality
        • 20.8.3.2.3. By End User
    • 20.8.4. North Africa Functional Brain Imaging Systems Market Analysis
      • 20.8.4.1. Introduction
      • 20.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.4.2.1. By Product
        • 20.8.4.2.2. By Modality
        • 20.8.4.2.3. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Deep Dive
    • 22.2.1. Koninklijke Philips N.V.
      • 22.2.1.1. Overview
      • 22.2.1.2. Product Portfolio
      • 22.2.1.3. Sales Footprint
      • 22.2.1.4. Key Financials
      • 22.2.1.5. SWOT Analysis
      • 22.2.1.6. Strategy Overview
        • 22.2.1.6.1. Marketing Strategy
        • 22.2.1.6.2. Product Strategy
        • 22.2.1.6.3. Channel Strategy
    • 22.2.2. General Electric Company
      • 22.2.2.1. Overview
      • 22.2.2.2. Product Portfolio
      • 22.2.2.3. Sales Footprint
      • 22.2.2.4. Key Financials
      • 22.2.2.5. SWOT Analysis
      • 22.2.2.6. Strategy Overview
        • 22.2.2.6.1. Marketing Strategy
        • 22.2.2.6.2. Product Strategy
        • 22.2.2.6.3. Channel Strategy
    • 22.2.3. Canon Medical Systems Corporation
      • 22.2.3.1. Overview
      • 22.2.3.2. Product Portfolio
      • 22.2.3.3. Sales Footprint
      • 22.2.3.4. Key Financials
      • 22.2.3.5. SWOT Analysis
      • 22.2.3.6. Strategy Overview
        • 22.2.3.6.1. Marketing Strategy
        • 22.2.3.6.2. Product Strategy
        • 22.2.3.6.3. Channel Strategy
    • 22.2.4. EB Neuro S.p.A.
      • 22.2.4.1. Overview
      • 22.2.4.2. Product Portfolio
      • 22.2.4.3. Sales Footprint
      • 22.2.4.4. Key Financials
      • 22.2.4.5. SWOT Analysis
      • 22.2.4.6. Strategy Overview
        • 22.2.4.6.1. Marketing Strategy
        • 22.2.4.6.2. Product Strategy
        • 22.2.4.6.3. Channel Strategy
    • 22.2.5. MinFound Medical Systems Co., Ltd
      • 22.2.5.1. Overview
      • 22.2.5.2. Product Portfolio
      • 22.2.5.3. Sales Footprint
      • 22.2.5.4. Key Financials
      • 22.2.5.5. SWOT Analysis
      • 22.2.5.6. Strategy Overview
        • 22.2.5.6.1. Marketing Strategy
        • 22.2.5.6.2. Product Strategy
        • 22.2.5.6.3. Channel Strategy
    • 22.2.6. Neurosoft
      • 22.2.6.1. Overview
      • 22.2.6.2. Product Portfolio
      • 22.2.6.3. Sales Footprint
      • 22.2.6.4. Key Financials
      • 22.2.6.5. SWOT Analysis
      • 22.2.6.6. Strategy Overview
        • 22.2.6.6.1. Marketing Strategy
        • 22.2.6.6.2. Product Strategy
        • 22.2.6.6.3. Channel Strategy
    • 22.2.7. Medtronic Plc
      • 22.2.7.1. Overview
      • 22.2.7.2. Product Portfolio
      • 22.2.7.3. Sales Footprint
      • 22.2.7.4. Key Financials
      • 22.2.7.5. SWOT Analysis
      • 22.2.7.6. Strategy Overview
        • 22.2.7.6.1. Marketing Strategy
        • 22.2.7.6.2. Product Strategy
        • 22.2.7.6.3. Channel Strategy
    • 22.2.8. Nihon Kohden Corporation
      • 22.2.8.1. Overview
      • 22.2.8.2. Product Portfolio
      • 22.2.8.3. Sales Footprint
      • 22.2.8.4. Key Financials
      • 22.2.8.5. SWOT Analysis
      • 22.2.8.6. Strategy Overview
        • 22.2.8.6.1. Marketing Strategy
        • 22.2.8.6.2. Product Strategy
        • 22.2.8.6.3. Channel Strategy
    • 22.2.9. Hitachi Medical Systems
      • 22.2.9.1. Overview
      • 22.2.9.2. Product Portfolio
      • 22.2.9.3. Sales Footprint
      • 22.2.9.4. Key Financials
      • 22.2.9.5. SWOT Analysis
      • 22.2.9.6. Strategy Overview
        • 22.2.9.6.1. Marketing Strategy
        • 22.2.9.6.2. Product Strategy
        • 22.2.9.6.3. Channel Strategy
    • 22.2.10. Elekta
      • 22.2.10.1. Overview
      • 22.2.10.2. Product Portfolio
      • 22.2.10.3. Sales Footprint
      • 22.2.10.4. Key Financials
      • 22.2.10.5. SWOT Analysis
      • 22.2.10.6. Strategy Overview
        • 22.2.10.6.1. Marketing Strategy
        • 22.2.10.6.2. Product Strategy
        • 22.2.10.6.3. Channel Strategy
    • 22.2.11. Siemens AG
      • 22.2.11.1. Overview
      • 22.2.11.2. Product Portfolio
      • 22.2.11.3. Sales Footprint
      • 22.2.11.4. Key Financials
      • 22.2.11.5. SWOT Analysis
      • 22.2.11.6. Strategy Overview
        • 22.2.11.6.1. Marketing Strategy
        • 22.2.11.6.2. Product Strategy
        • 22.2.11.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology